ARTICLE | Company News
Advaxis, University of Pennsylvania deal
November 21, 2011 8:00 AM UTC
The university granted Advaxis an exclusive license to interferon-stimulated gene 15 (ISG15) for use in Advaxis' Listeria monocytogenes Listeriolysin O (Lm-LLO) based immunotherapies. Advaxis said th...